 |
Lotus
Pharmaceuticals Announces Third Quarter
Fiscal 2011 Financial Results
2011/11/11 |
|
Lotus
Pharmaceuticals Announces Second
Quarter Fiscal 2011 Financial Results
2011/08/15 |
|
Lotus
Pharmaceuticals Announces First Quarter
Fiscal 2011 Financial Results
2011/05/16 |
|
Lotus
Pharmaceuticals Responds to Investor
Concerns in Exclusive Interview
2011/04/25 |
|
Lotus
Pharmaceuticals Announces Fiscal 2010
Financial Results
2011/03/28 |
|
Lotus
Pharmaceuticals to Expand Construction
of Beijing Facility
2011/02/04 |
|
Lotus
Pharmaceuticals Provides Inner Mongolia
Land Price Guidance from Cha You Qian
Qi Government Split
2011/01/27 |
|
Lotus
Pharmaceuticals Announces Fiscal 2010
Financial Results
2011/03/28 |
|
Lotus
Pharmaceuticals Announces Approval of
Reverse Stock Split
2010/12/31 |
|
Lotus
Pharmaceuticals Announces Update on
Land in Inner Mongolia Company to Sell
or Transfer Land Parcel to Focus on
Core Business in Beijing
2010/12/09 |
|
Lotus
Pharmaceuticals Announces Participation
in PHARMCHINA's 64th National Drug Fair
Conference
2010/12/09 |
|
Lotus
Pharmaceuticals Announces Third Quarter
2010 Financial Results
2010/11/11 |
|
Lotus
Pharmaceuticals Announces Conference
Call to Discuss Third Quarter 2010
Financial Results
2010/11/10 |
|
Lotus
Pharmaceuticals Receives SFDA Approval
to Initiate Phase I Clinical Trials of
Asthma Drug R-Bambuterol
2010/10/27 |
|
Lotus
Pharmaceuticals Preparing to Apply for
National Exchange Listing
2010/10/22 |
|
Lotus
Pharmaceuticals Announces New Patent
for Controlled-Release Diabetes
Drug 2010/10/19 |
|
Lotus
Pharmaceuticals Retains Sichenzia Ross
Friedman Ference LLP as General Legal
Counsel
2010/10/06 |
|
Lotus
Pharmaceuticals Announces Two Senior
Management Appointments
2010/09/23 |
|
Lotus
Pharmaceuticals Enter R-Bambuterol®
Clinical Trial I
2010/08/26 |
|
Lotus
Pharmaceuticals Reports Strong Second
Quarter 2010 Financial
Results
2010/08/16 |
|
Lotus
Completed R-Bambuterol’s Pilot
Scale Production for Clinical
Trials 2010/08/03 |
|
Lotus
Pharmaceuticals Terminates
SEDA 2010/07/22 |
|
Lotus
Pharmaceuticals, Inc. Reports Strong
First Quarter 2010 Financial
Results
2010/05/14 |
|
Lotus
Pharmaceuticals’ Laevo-Bambuterol
Received SFDA Approval to Commence
Clinical Trials
2010/04/29 |
|
Lotus
Pharmaceuticals’ Innovative Drug
to Receive SFDA Fast Track
Approval
2010/04/20 |
|
Lotus
Pharmaceuticals, Inc. Reports Full Year
2009 Financial Results
2010/04/01 |
|
Lotus
Pharmaceuticals Reports Groundbreaking
Ceremony
2010/03/10 |
|
YA
Global Master SPV Ltd Invests up to
US$10,000,000 in Lotus Pharmaceutical,
Inc. through Equity Line
Facility
2010/03/03 |
|
Lotus
Pharmaceuticals Announces New
Prescription Drugs
2010/03/02 |
|
Lotus
Pharmaceuticals to Commence
Sarbanes-Oxley Compliance
Project
2010/03/01 |
|
Lotus
Pharmaceuticals Announces Key
Changes
2010/01/15 |
|
Lotus
Pharmaceuticals, Inc. Appoints OTC
Division Head
2009/12/10 |
|
Lotus
Pharmaceuticals, Inc. Strengthens
Beijing Presence with Direct Sales to
Drug Stores
2009/11/30 |
|
Lotus
Pharmaceuticals, Inc. to Exhibit at the
62nd
PHARMCHINA
2009/11/24 |
|
Lotus
Pharmaceuticals,Inc. Reports
Third-Quarter 2009
Results
2009/11/16 |
|
Lotus
Pharmaceuticals,Inc. Announces Certain
Clarification
2009/11/05 |
|
Lotus
Pharmaceuticals, Inc. Announces 2010
Growth Strategy 2009/10/19
|
|
Lotus Reports Second
Quarter 2009 Financial
Results
2009/08/14 |
|
Lotus Pharmaceuticals,
Inc. Announces Patent Pending
Gliclazide-Controlled Release
Tablets
2009/07/30 |
|
Lotus Pharmaceuticals,
Inc. Again Awarded GSP
Certification 2009/06/29 |
|
Lotus Pharmaceuticals,
Inc. Reports First Quarter 2009
Financial Results
2009/05/18 |
|
Lotus Pharmaceuticals,
Inc. Reports Strong 2008 Financial
Results 2009/04/22 |
|
Lotus Pharmaceuticals,
Inc. Purchases Intellectual Property
Rights to an Established Prescription
Drug 2009/02/18 |
|
Lotus Pharmaceuticals,
Inc. Purchases Land Use Rights to Grow
its Business and Reduce Costs
2009/02/05 |
|
Lotus Pharmaceuticals
Announces Third Quarter 2008
Results 2008/11/18 |
|
Lotus Pharmaceuticals
Announces Second Quarter 2008 Results
2008/08/18 |
|
|
|
Lotus Pharmaceuticals,
Inc. Reaffirms its Confidence in
Meeting its Make Good Target for Fiscal
Year 2008 2008/05/30 |
|
|
|
Lotus Pharmaceuticals,
Inc. Announces Resignation of Director
Mel Rothberg 2008/04/24 |
|
Lotus Pharmaceuticals,
Inc. Announces Fourth Quarter and
Fiscal Year 2007 Results
2008/04/17 |
|
Lotus Pharmaceuticals
Raises $5 Million in Private Placement
2008/02/26 |
|
Lotus Pharmaceuticals,
Inc. Implements
Environmentally-friendly Cost Saving
Strategies
2008/02/07 |
|
Lotus Pharmaceuticals,
Inc. Achieves Significant Milestones in
the Development of Isosorbide
Mononitrate Sustained Release
Tablets 2008/02/26 |
| |
|
